SPTLC3对线粒体复合物I活性至关重要并参与缺血性心肌病
该研究在终末期缺血性心肌病患者和小鼠缺血性心肌病模型中分析鞘脂代谢谱,发现SPTLC3在缺血条件下经HIF1α诱导,产生含16碳鞘氨醇碱基的非典型鞘脂;心肌细胞特异性敲除SPTLC3可减轻慢性缺血下的氧化应激、纤维化和肥厚,改善心功能并提高生存率,机制与改变线粒体复合物I的膜环境和亚基组成、降低其活性有关。
要点
- SPTLC3在缺血性心肌病中经HIF1α诱导,产生非典型鞘脂。
- 心肌细胞敲除SPTLC3可减轻慢性缺血下的氧化应激、纤维化和肥厚。
- SPTLC3缺失通过改变线粒体复合物I膜环境降低其活性。
核心结论
- SPTLC3对电子传递链功能至关重要,并通过调节复合物I活性参与缺血性损伤。
研究设计与样本
- 分析终末期缺血性心肌病患者心脏组织和小鼠缺血性心肌病模型的靶向脂质组学。
- 使用染色质免疫沉淀确定缺血条件下HIF1α对SPTLC3的调控。
- 在生成的cSPTLC3KO转基因小鼠中评估转录组学、脂质组学、代谢组学、超声心动图、线粒体电子传递链、线粒体膜流动性和膜电位。
- 对cSPTLC3KO小鼠进行永久性非再灌注心肌梗死后的形态学和功能研究。
主要发现
- SPTLC3在人类和小鼠缺血性心肌病模型中均被诱导,导致产生含16碳鞘氨醇碱基的非典型鞘脂,引起细胞鞘脂组成广泛变化。
- 该诱导部分归因于缺血条件下HIF1α的转录调控。
- 小鼠心肌细胞特异性敲除SPTLC3可减轻慢性缺血下的氧化应激、纤维化和肥厚,改善心脏功能并提高生存率,同时增加酮体和葡萄糖底物代谢利用。
- 敲除SPTLC3机制上改变电子传递链线粒体复合物I的膜环境和亚基组成,降低其活性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease contexts, and cellular roles are not completely understood. Sphingolipids are produced by the serine palmitoyltransferase enzyme, canonically composed of 2 subunits, SPTLC1 (serine palmitoyltransferase long chain base subunit 1) and SPTLC2 (serine palmitoyltransferase long chain base subunit 2). Noncanonical sphingolipids are produced by a more recently described subunit, SPTLC3 (serine palmitoyltransferase long chain base subunit 3). METHODS: The noncanonical (d16) and canonical (d18) sphingolipidome profiles in cardiac tissues of patients with end-stage ischemic cardiomyopathy and in mice with ischemic cardiomyopathy were analyzed by targeted lipidomics. Regulation of SPTLC3 by HIF1α under ischemic conditions was determined with chromatin immunoprecipitation. Transcriptomics, lipidomics, metabolomics, echocardiography, mitochondrial electron transport chain, mitochondrial membrane fluidity, and mitochondrial membrane potential were assessed in the cSPTLC3KO transgenic mice we generated. Furthermore, morphological and functional studies were performed on cSPTLC3KO mice subjected to permanent nonreperfused myocardial infarction. RESULTS: Herein, we report that SPTLC3 is induced in both human and mouse models of ischemic cardiomyopathy and leads to production of atypical sphingolipids bearing 16-carbon sphingoid bases, resulting in broad changes in cell sphingolipid composition. This induction is in part attributable to transcriptional regulation by HIF1α under ischemic conditions. Furthermore, cardiomyocyte-specific depletion of SPTLC3 in mice attenuates oxidative stress, fibrosis, and hypertrophy in chronic ischemia, and mice demonstrate improved cardiac function and increased survival along with increased ketone and glucose substrate metabolism utilization. Depletion of SPTLC3 mechanistically alters the membrane environment and subunit composition of mitochondrial complex I of the electron transport chain, decreasing its activity. CONCLUSIONS: Our findings suggest a novel essential role for SPTLC3 in electron transport chain function and a contribution to ischemic injury by regulating complex I activity.
引用
- Kovilakath A, Mauro AG, Valentine YA, et al. SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy. Circulation. 2024. PMID: 38660786. doi:10.1161/CIRCULATIONAHA.123.066879
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。